Bunge Global (BG) has put capital allocation in the spotlight, announcing a $1.2b senior unsecured notes offering, a new $3b share repurchase program, and an acquisition of protein businesses from International Flavors & Fragrances.
See our latest analysis for Bunge Global.
The recent capital return announcements and protein acquisition come at a time when momentum is building, with a 30 day share price return of 10.93% and a 1 year total shareholder return of 82.26%.
If you are weighing Bunge Global against other potential ideas, this could be a good moment to widen your search and check out 20 top founder-led companies.
With the stock up 82.26% over the past year and trading near an average analyst price target that implies limited upside, you have to ask: is Bunge Global still undervalued, or is the market already pricing in future growth?
Most Popular Narrative: 2.3% Undervalued
The most followed narrative places Bunge Global’s fair value at $132.50, only slightly above the last close of $129.42, which keeps expectations tight.
The completion and integration of the Viterra merger provides substantial cost and commercial synergies, expands Bunge's global origination, processing, and distribution footprint, and positions the company to capture greater market share in high-growth markets, which is set to drive higher topline growth and improved operating margins.
Want to see what kind of revenue path and margin reset sit behind that fair value, and how analysts translate it into future earnings power and a specific multiple target?
Result: Fair Value of $132.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you still need to watch for policy shifts in biofuels and any bumps in the Viterra integration, which could pressure margins and challenge the current fair value story.
Find out about the key risks to this Bunge Global narrative.
Next Steps
Given this mix of optimism and concern around Bunge Global, it makes sense to move quickly and inspect the numbers yourself before opinions harden. To weigh up both sides of the story in one place, start with the 2 key rewards and 4 important warning signs
Looking for more investment ideas?
If you stop with just one stock, you risk missing out on other opportunities that could fit your goals even better, so broaden your watchlist now.
- Zero in on quality at a discount by scanning 58 high quality undervalued stocks that combine solid fundamentals with prices that may not fully reflect them yet.
- Strengthen your income stream by reviewing 13 dividend fortresses that currently offer higher yields and may appeal if you prioritise regular cash returns.
- Dial down portfolio stress by focusing on 68 resilient stocks with low risk scores where business fundamentals and risk scores may better align with a more cautious approach.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com